Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 123,305 | 92,840 | 102,149 | 60,431 | 91,196 |
| Marketable Securities | 305,033 | 310,388 | 296,500 | 284,978 | 266,433 |
| Receivables | 44,216 | 48,134 | 49,063 | 49,508 | 44,811 |
| Income taxes - deferred | 14,293 | 18,560 | N/A | N/A | N/A |
| TOTAL | $491,847 | $473,976 | $450,621 | $400,848 | $410,351 |
| Non-Current Assets | |||||
| PPE Net | 23,543 | 23,261 | 24,275 | 24,825 | 22,214 |
| Investments And Advances | 80,064 | 85,154 | 112,534 | 112,150 | 59,370 |
| Other Non-Current Assets | 15,388 | 11,456 | 2,133 | 2,214 | 2,194 |
| TOTAL | $118,995 | $119,871 | $138,942 | $139,189 | $83,778 |
| Total Assets | $610,842 | $593,847 | $589,563 | $540,037 | $494,129 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,242 | 8,870 | 7,026 | 9,403 | 7,648 |
| Accrued Expenses | 23,689 | 18,596 | 15,191 | 13,308 | 13,345 |
| TOTAL | $30,931 | $27,466 | $22,217 | $22,711 | $20,993 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,800 | 8,800 | 0 | 0 | 0 |
| TOTAL | $8,800 | $8,800 | $N/A | $N/A | $N/A |
| Total Liabilities | $39,731 | $36,266 | $22,217 | $22,711 | $20,993 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,384 | N/A | 97,779 | 96,432 | 96,201 |
| Common Shares | 924 | 940 | 976 | 964 | 962 |
| Retained earnings | -3,758 | -10,465 | -20,887 | -54,138 | -89,498 |
| Other shareholders' equity | 262 | 139 | 1,155 | 1,854 | 2,672 |
| TOTAL | $571,111 | $557,581 | $567,346 | $517,326 | $473,136 |
| Total Liabilities And Equity | $610,842 | $593,847 | $589,563 | $540,037 | $494,129 |